['chronic hepatitis b']
['nvr 3-778', 'placebo for nvr 3-778', 'pegasys']

        Healthy volunteers may be male or female between 18 and 65 years old with a BMI of
        18-32kg/m2. They must be in good health not have any health condition which could interfere
        with the absorption, distribution or elimination of study drug, or with the clinical and
        laboratory assessments in this study.

        Patients enrolling in Part II of the study, may be male or female between 18 and 65 years
        of age, with a BMI of 18-35kg/m2. Patients must have HBeAg positive, chronic hepatitis B
        with no history of clinical decompensation, and must not have been treated for hepatitis B
        before.
      